Dark

Check out our API

ELEV
Elevation Oncology, Inc. Common stock
stock NASDAQ

Inactive

Jul 22, 2025

0.3650USD-2.119%(-0.0079)4,819,177

Pre-market

0.00USD-100.000%(-0.37)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 10, 2022

07:01AM EST Elevation Oncology Highlights 2021 Achievements and Outlines Expected 2022 PR Newswire

Jan 6, 2022

08:01AM EST Elevation Oncology to Present at the H.C. Wainwright BIOCONNECT Virtual PR Newswire

Jan 5, 2022

08:01AM EST Elevation Oncology to Present at the 40th Annual J.P. Morgan Healthcare PR Newswire

Dec 23, 2021

06:09AM EST HC Wainwright & Co. Initiates Coverage On Elevation Oncology with Buy Rating, Announces Price Target of $12 Benzinga

Dec 7, 2021

10:17AM EST Mid-Morning Market Update: Markets Open Higher; AutoZone Tops Q1 Views Benzinga

Nov 18, 2021

08:01AM EST Elevation Oncology to Present at the Piper Sandler 33rd Annual Virtual PR Newswire

Nov 12, 2021

07:46AM EST Elevation Oncology Q3 EPS $(0.53) Up From $(3.80) YoY Benzinga

07:35AM EST Elevation Oncology Q3 Loss Per Share $0.53 Vs Loss $3.80 Last Year RTTNews

07:31AM EST Elevation Oncology Reports Third Quarter 2021 Financial Results PR Newswire

Oct 20, 2021

07:01AM EDT Elevation Oncology Announces the Promotion of Valerie Malyvanh Jansen, M.D., PR Newswire

Oct 14, 2021

07:02AM EDT Presentation at the Australasian Gastro-Intestinal Trials Group 2021 Annual Scientific Meeting PR Newswire

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 7, 2021

07:01AM EDT Elevation Oncology to Present at the H.C. Wainwright 23rd Annual Global PR Newswire

Aug 12, 2021

04:35PM EDT Elevation Oncology Q2 EPS $(4.84), Down From $(4.32) YoY Benzinga

04:06PM EDT Elevation Oncology Reports Second Quarter 2021 Financial Results PR Newswire

Aug 4, 2021

07:02AM EDT Elevation Oncology to Present at the 12th Annual Wedbush PacGrow Healthcare PR Newswire

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 23, 2021

07:45AM EDT The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs Benzinga

Jul 22, 2021

11:34AM EDT The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO Benzinga

Jul 20, 2021

11:52AM EDT UPDATE: SVB Leerink On Elevation Oncology Outperform Initiation: Firm Sees Seribantumab Potential To Be A 'Best-In-Class Asset For NRG1 Fusion Protein-Positive'; Notes Pipeline Expansion Plans In Precision Oncology & Partnership With Caris Life Sciences Benzinga

10:14AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 Benzinga

08:56AM EDT Wedbush Initiates Coverage On Elevation Oncology with Outperform Rating, Announces Price Target of $27 Benzinga

06:38AM EDT 06:38 Tuesday, July 20, 2021Wedbush (RTTNews) - Wedbush Initiates Elevate, Inc. (ELEV) At Outperform With $27 Price Target RTTNews

06:32AM EDT Cowen & Co. Initiates Coverage On Elevation Oncology with Outperform Rating Benzinga

06:19AM EDT SVB Leerink Initiates Coverage On Elevation Oncology with Outperform Rating, Announces Price Target of $20 Benzinga

Jul 13, 2021

08:05AM EDT The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data Benzinga

Jul 7, 2021

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jun 30, 2021

07:29AM EDT The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs Benzinga

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 25, 2021

01:10PM EDT Elevation Oncology Shares Open For Trade At $14; IPO Priced At $16/Share Benzinga

11:22AM EDT Elevation Oncology Shares Indicating $15.30 On 261K Shares Benzinga

10:58AM EDT Elevation Oncology Shares Indicating $15.51 Benzinga

09:12AM EDT Elevation Oncology Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $16/Share Benzinga

Jun 24, 2021

09:00PM EDT Elevation Oncology Prices IPO Of 6.25 Mln Shares At $16/shr RTTNews

08:45PM EDT Elevation Oncology Announces Pricing of Initial Public Offering PR Newswire

Share